| MiR-625-5p is a potential therapeutic target in sepsis by regulating CXCL16/CXCR6 axis and endothelial barrier. | MiR-625-5p is a potential therapeutic target in sepsis by regulating CXCL16/CXCR6 axis and endothelial barrier.
Huang X, Fei Y, Qiu X, Qian T, Shang Q, Cui J, Song Y, Sheng S, Xiao W, Yu Q, Wang T, Wang X. | 08/5/2024 |
| Serum CXCL16: A new predictor of liver inflammation in patients with chronic hepatitis B. | Serum CXCL16: A new predictor of liver inflammation in patients with chronic hepatitis B.
Wan Y, Mao M, Li M, Liu J, Tong X, Wang J, Li J, Yin S, Wu C. | 01/29/2024 |
| Identification of CXCL16 as a diagnostic biomarker for obesity and intervertebral disc degeneration based on machine learning. | Identification of CXCL16 as a diagnostic biomarker for obesity and intervertebral disc degeneration based on machine learning.
Liu J, Zhang J, Zhao X, Pan C, Liu Y, Luo S, Miao X, Wu T, Cheng X., Free PMC Article | 12/6/2023 |
| CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer. | CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer.
Zajkowska M, Dulewicz M, Kulczyńska-Przybik A, Safiejko K, Juchimiuk M, Konopko M, Kozłowski L, Mroczko B., Free PMC Article | 11/1/2023 |
| Upregulation of IL-33, CCL2, and CXCL16 levels in Brazilian pregnant women infected by Toxoplasma gondii. | Upregulation of IL-33, CCL2, and CXCL16 levels in Brazilian pregnant women infected by Toxoplasma gondii.
Santos PVD, Toledo DNM, Guimarães NS, Perucci LO, Andrade-Neto VF, Talvani A. | 06/1/2023 |
| ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer. | ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer.
Jung HY, Lee DK, Lee M, Choi SH, Park JD, Ko ES, Lee J, Park KS, Jung HY., Free PMC Article | 04/1/2023 |
| Convergent transcriptomic and genomic evidence supporting a dysregulation of CXCL16 and CCL5 in Alzheimer's disease. | Convergent transcriptomic and genomic evidence supporting a dysregulation of CXCL16 and CCL5 in Alzheimer's disease.
Li X, Zhang DF, Bi R, Tan LW, Chen X, Xu M, Yao YG., Free PMC Article | 02/11/2023 |
| CXCL16 inhibits epithelial regeneration and promotes fibrosis during the progression of radiation enteritis. | CXCL16 inhibits epithelial regeneration and promotes fibrosis during the progression of radiation enteritis.
Cui Y, Wu H, Liu Z, Ma T, Liang W, Zeng Q, Chen D, Qin Q, Huang B, Wang MH, Huang X, He Y, Kuang Y, Sugimoto S, Sato T, Wang L. | 01/21/2023 |
| CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19. | CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19.
Gregersen I, Ueland T, Holter JC, Olsen MB, Michelsen AE, Murphy SL, Tveita AA, Henriksen KN, Hoel H, Nordberg LB, Holten AR, Edvardsen T, Yang K, Heggelund L, Trøseid M, Müller F, Kildal AB, Dyrhol-Riise AM, Barratt-Due A, Dahl TB, Aukrust P, Halvorsen B, NOR-SOLIDARITY consortium, The Norwegian SARS-CoV-2 Study Group investigators., Free PMC Article | 01/11/2023 |
| Platelet SR-PSOX/CXCL16-CXCR6 Axis Influences Thrombotic Propensity and Prognosis in Coronary Artery Disease. | Platelet SR-PSOX/CXCL16-CXCR6 Axis Influences Thrombotic Propensity and Prognosis in Coronary Artery Disease.
Guan T, Emschermann F, Schories C, Groga-Bada P, Martus P, Borst O, Gawaz M, Geisler T, Rath D, Chatterjee M., Free PMC Article | 10/22/2022 |
| Metabolic Syndrome in Psoriasis Is Associated With Upregulation of CXCL16 on Monocytes and a Dysbalance in Innate Lymphoid Cells. | Metabolic Syndrome in Psoriasis Is Associated With Upregulation of CXCL16 on Monocytes and a Dysbalance in Innate Lymphoid Cells.
Schielke L, Zimmermann N, Hobelsberger S, Steininger J, Strunk A, Blau K, Hernandez J, Künzel S, Ziegenbalg R, Rösing S, Beissert S, Abraham S, Günther C., Free PMC Article | 07/9/2022 |
| Clinical significance and role of CXCL16 in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. | Clinical significance and role of CXCL16 in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Li W, Zhang Q, Xie L, Fan N, Liu Z, Zhang L, Zhang J, Tang S, Wang W, Liu X, Li X, Wang H, Zhao J, Huang Y, Zhang J. | 04/30/2022 |
| P2X7 receptor inhibition attenuates podocyte injury by oxLDL through deregulating CXCL16. | P2X7 receptor inhibition attenuates podocyte injury by oxLDL through deregulating CXCL16.
Zhu Y, Li Q, Chen Y, Tian M, Xun W, Sun S. | 04/16/2022 |
| Interleukin-18 accelerates cardiac inflammation and dysfunction during ischemia/reperfusion injury by transcriptional activation of CXCL16. | Interleukin-18 accelerates cardiac inflammation and dysfunction during ischemia/reperfusion injury by transcriptional activation of CXCL16.
Zhao G, Zhang H, Zhu S, Wang S, Zhu K, Zhao Y, Xu L, Zhang P, Xie J, Sun A, Zou Y, Ge J. | 04/9/2022 |
| CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways. | CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways.
Han J, Fu R, Chen C, Cheng X, Guo T, Huangfu L, Li X, Du H, Xing X, Ji J., Free PMC Article | 03/19/2022 |
| C-X-C motif chemokine 16, modulated by microRNA-545, aggravates myocardial damage and affects the inflammatory responses in myocardial infarction. | C-X-C motif chemokine 16, modulated by microRNA-545, aggravates myocardial damage and affects the inflammatory responses in myocardial infarction.
Liang FQ, Gao JY, Liu JW., Free PMC Article | 02/5/2022 |
| Application effect of tirofiban on percutaneous coronary intervention in patients with acute coronary syndrome and its postoperative effect on C-X-C motif chemokine ligand 16 level and myocardial perfusion. | Application effect of tirofiban on percutaneous coronary intervention in patients with acute coronary syndrome and its postoperative effect on C-X-C motif chemokine ligand 16 level and myocardial perfusion.
Xu M, Zhang C, Yu X, Zhu L, Tan H, Wang C, Zhao L, Zhao Z. | 01/22/2022 |
| CXCL16/CXCR6 Axis in Adipocytes Differentiated from Human Adipose Derived Mesenchymal Stem Cells Regulates Macrophage Polarization. | CXCL16/CXCR6 Axis in Adipocytes Differentiated from Human Adipose Derived Mesenchymal Stem Cells Regulates Macrophage Polarization.
Lee SC, Lee YJ, Choi I, Kim M, Sung JS., Free PMC Article | 01/8/2022 |
| Evaluation of serum CXC chemokine ligand 16 (CXCL16) as a novel inflammatory bio- marker or familial Mediterranean fever disease | Evaluation of serum CXC chemokine ligand 16 (CXCL16) as a novel inflammatory bio- marker or familial Mediterranean fever disease.
Akyol T, Düzenli T, Tanoğlu A., Free PMC Article | 01/1/2022 |
| Circ_0000524/miR-500a-5p/CXCL16 axis promotes podocyte apoptosis in membranous nephropathy. | Circ_0000524/miR-500a-5p/CXCL16 axis promotes podocyte apoptosis in membranous nephropathy.
Sun Z, Xu Q, Ma Y, Yang S, Shi J. | 12/4/2021 |
| Role of CXCL16 in BLM-induced epithelial-mesenchymal transition in human A549 cells. | Role of CXCL16 in BLM-induced epithelial-mesenchymal transition in human A549 cells.
Ma Z, Ma C, Zhang Q, Bai Y, Mu K, Liu X, Yang Q., Free PMC Article | 10/30/2021 |
| The chemokine CXCL16 can rescue the defects in insulin signaling and sensitivity caused by palmitate in C2C12 myotubes. | The chemokine CXCL16 can rescue the defects in insulin signaling and sensitivity caused by palmitate in C2C12 myotubes.
Bitsi S. | 10/9/2021 |
| Expression and significance of serum soluble fms-like tyrosine kinase 1 (sFlt-1), CXC chemokine ligand 16 (CXCL16), and lipocalin 2 (LCN-2) in pregnant women with preeclampsia. | Expression and significance of serum soluble fms-like tyrosine kinase 1 (sFlt-1), CXC chemokine ligand 16 (CXCL16), and lipocalin 2 (LCN-2) in pregnant women with preeclampsia.
Li L, Ling B, Mei J, Wang Y, Zhang J, Zhao X. | 08/14/2021 |
| The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases. | The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases.
Korbecki J, Bajdak-Rusinek K, Kupnicka P, Kapczuk P, Simińska D, Chlubek D, Baranowska-Bosiacka I., Free PMC Article | 07/10/2021 |
| Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease. | Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease.
Lee YH, Kim KP, Park SH, Kim DJ, Kim YG, Moon JY, Jung SW, Kim JS, Jeong KH, Lee SY, Yang DH, Lim SJ, Woo JT, Rhee SY, Chon S, Choi HY, Park HC, Jo YI, Yi JH, Han SW, Lee SH. | 05/15/2021 |